Our pipeline is a strategic bridge Between cutting-edge science and real-world impact Strategic Partnerships and Collaborations We have deepened our commercial business pipeline through global in-licensing and strategic partnerships. These partnerships significantly strengthen our portfolio to bring differentiated science for patients across the world. Oncology Solid Tumor QiNHAYO™ (Envafolimab) (SubQ next gen PDL1) /3DM – […]